• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: PRINGY JUVEDERM VOLLURE XC 2X1 ML; IMPLANT, DERMAL, FOR AESTHETIC USE

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

PRINGY JUVEDERM VOLLURE XC 2X1 ML; IMPLANT, DERMAL, FOR AESTHETIC USE Back to Search Results
Catalog Number 95661
Medical Device Problem Code Adverse Event Without Identified Device or Use Problem (2993)
Health Effect - Clinical Code Nodule (4551)
Date of Event 11/01/2024
Type of Reportable Event Serious Injury
Additional Manufacturer Narrative
Clarification to h.6.Type of investigation code: the filler was injected into the patient and is not accessible for return.The syringe was not returned for evaluation.The event is a physiological complication and analysis of the device generally does not assist abbvie in determining a probable cause for this event.Further information regarding event, product, or patient details has been requested.No additional information is available at this time.A review of the device history record has been initiated.If any new, changed or corrected information is noted, a supplemental medwatch will be submitted.This is a known potential adverse event addressed in the product labeling.
 
Event or Problem Description
Healthcare professional reported injecting a patient in the nasolabial folds and marionette lines with 2 syringes of juvéderm vollure¿ xc.Six months later, the patient was injected in the nasolabial folds with 1 syringe of juvéderm vollure¿ xc.Twenty-one months later, the patient experienced ¿pain, swelling, and nodules¿ in the nasolabial folds and marionette lines.An ultrasound was performed by a dermatologist, where no cysts were found.Four months after onset, the patient contacted the injecting healthcare professional and was treated with hylenex.More hylenex was given 12 days later, again 2 days later, a week later, five days later, and two days later.The event achieved 90% clearance.Event is ongoing.This file captured the additional injection.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
JUVEDERM VOLLURE XC 2X1 ML
Common Device Name
IMPLANT, DERMAL, FOR AESTHETIC USE
Manufacturer (Section D)
PRINGY
route de promery
zone artisanale de pre-mairy
pringy 74370
FR  74370
Manufacturer (Section G)
PRINGY
route de promery
zone artisanale de pre-mairy
pringy 74370
FR   74370
Manufacturer Contact
terry ingram
2525 dupont drive
irvine, CA 92612
8479366324
MDR Report Key24047424
Report Number3005113652-2026-00018
Device Sequence Number9745014
Product Code LMH
UDI-Device Identifier10888628034471
UDI-Public(01)10888628034471(10)1000510227(11)220328(17)240228
Combination Product (Y/N)Y
Initial Reporter StatePA
Initial Reporter CountryUS
PMA/510(K) Number
P110033
Number of Events Summarized1
Summary Report (Y/N)N
Device Implanted Year2023
Reporter Type Manufacturer
Report Source Health Professional,Company Representative
Initial Reporter Occupation Nurse
Type of Report Initial
Report Date (Section B) 01/12/2026
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Operator of Device Health Professional
Device Expiration Date02/28/2024
Device Catalogue Number95661
Device Lot Number1000510227
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? Yes
Type of Report(Section G)Initial
Initial Date Received by Manufacturer 01/08/2026
Initial Report FDA Received Date01/12/2026
Was Device Evaluated by Manufacturer? (Y/N) No
Date Device Manufactured05/28/2022
Is the Device Labeled for Single Use? (Y/N) Yes
Is This a Single-Use Device that was
Reprocessed and Reused on a Patient? (Y/N)
No
Usage of Device Unknown
Patient Sequence Number1
Outcome Attributed to Adverse Event Required Intervention;
Patient Age55 YR
Patient SexFemale
-
-